DADC
USNA icon

D.A. Davidson & Co’s Usana Health Sciences USNA Stock Holding History

D.A. Davidson & Co’s Portfolio USNA Stock Details USNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-1,132
Closed -$69K – 2496
2016
Q4 		$69K Sell
1,132
-656
-37% -$42.7K ﹤0.01% 1464
2016
Q3 		$123K Sell
1,788
-532
-23% -$35.1K ﹤0.01% 1155
2016
Q2 		$129K Sell
2,320
-398
-15% -$24K ﹤0.01% 1030
2016
Q1 		$165K Sell
2,718
-3,412
-56% -$201K 0.01% 918
2015
Q4 		$391K Sell
6,130
-210
-3% -$13.6K 0.01% 612
2015
Q3 		$424K Sell
6,340
-1,936
-23% -$137K 0.01% 585
2015
Q2 		$565K Sell
8,276
-346
-4% -$22K 0.02% 542
2015
Q1 		$479K Buy
+8,622
New +$442K 0.02% 585

Other funds holding USNA

Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return
Nordea Investment Management
Nordea Investment Management Stockholm, Sweden $107B AUM 24.58% 1-Year Est. Return
TA
Teachers Advisors New York $81.7B AUM 13.62% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM

D.A. Davidson & Co's USNA Position: Q1 2017 in Review

D.A. Davidson & Co sold out of Usana Health Sciences (USNA) in Q1 2017, closing a stake of 1,132 shares — an estimated $69K sold.

D.A. Davidson & Co first reported a position in USNA in Q1 2015 and held it in 8 quarters. The position peaked at $565K in Q2 2015. 155 funds tracked by Wall St. Rank hold USNA as of Q1 2017.

  • D.A. Davidson & Co reported no remaining Usana Health Sciences position as of Q1 2017 after selling out during the quarter.
  • D.A. Davidson & Co sold 1,132 Usana Health Sciences shares in Q1 2017, an estimated $69K.
  • D.A. Davidson & Co first reported a position in Usana Health Sciences in Q1 2015 and held it in 8 quarters.
  • D.A. Davidson & Co's Usana Health Sciences position peaked at $565K in Q2 2015.
  • 155 funds tracked by Wall St. Rank held Usana Health Sciences as of Q1 2017.

Based on D.A. Davidson & Co's 13F filing for Q1 2017, filed 12 May 2017.